KRAS and colorectal carcinoma: It was reported that lncRNAs trim many signaling paths associated with CRC, including Wnt/β-catenin, EGFR/IGF-IR, KRAS, PI-3-kinase, TGF-β, p53, and the epithelial—mesenchymal transition (EMT) program [67].